Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization
Archives of Iranian Medicine · 2025
DOI: 10.34172/aim.33457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Iranian Medicine, 2025. Verfasst von Sareh Sadidi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Hemoptysis, Bronchial Arteries, Embolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Despite the high success rate of bronchial artery embolization (BAE), hemoptysis probably recurs. This study investigated risk factors of 12-month hemoptysis recurrence after BAE in an Iranian population.
Methods
In this prospective cohort, we followed up 101 patients for 12 months after BAE. Outcome of interest was recurrence of hemoptysis. Target arteries were super-selectively catheterized and embolized with non-spherical polyvinyl alcohol particles (150–700 µm). Success of BAE was confirmed using post-BAE angiography. Independent t-test, and chi-square and Fisher’s exact test were used to compare variables between "recurrence" and "non-recurrence" groups. We investigated predictors of recurrent hemoptysis through univariate and multivariate logistic regression modeling. We analyzed receiver operating characteristic curve to find the optimal cutoff point for continuous risk factors. Recurrence-free rates stratified by risk factors were plotted against time using the Kaplan-Meier method.
Results
BAE was immediately successful in all patients. During the 12-month follow-up, hemoptysis recurred in 13.9% (95% CI: 8.2–21.6) of participants. Mean (±standard deviation) recurrence-free time was 6.9 (±3.3) months. Lung destruction (OR=5.40 [95% CI: 1.41–20.58], P value=0.013) and arterial diameter≥2 mm (12.51 [1.51–103.59], P value=0.019) were independent predictors of 12-month hemoptysis recurrence.
Conclusion
Patients with destroyed lungs and embolized arteries wider than 2.0 mm are at higher risk of hemoptysis recurrence in the first year after BAE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Mashhad University of Medical Sciences, Mashhad, Iran.
- Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Community Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Sareh Sadidi, Farzin Roozafzai, Sirous Nekooei, Lida Jarahi, Farzaneh Khoroushi
Zitieren
APA
Sadidi, S., Roozafzai, F., Nekooei, S., Jarahi, L., & Khoroushi, F. (2025). Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization. Archives of Iranian Medicine. https://doi.org/10.34172/aim.33457
Vancouver
Sadidi S, Roozafzai F, Nekooei S, Jarahi L, Khoroushi F. Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization. Archives of Iranian Medicine. 2025. doi:10.34172/aim.33457
BibTeX
@article{Sadidi2025,
author = {Sadidi, Sareh and Roozafzai, Farzin and Nekooei, Sirous and Jarahi, Lida and Khoroushi, Farzaneh},
title = {Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization},
journal = {Archives of Iranian Medicine},
year = {2025},
doi = {10.34172/aim.33457}
}
EUVIMED